What kind of consistency can industry expect from the FDA post - Chartable

The Biopharma Pod

What kind of consistency can industry expect from the FDA post pandemic?

Listen now

Description

How the US Food and Drug Administration (FDA) exercises flexibility has been an important and emerging issue for the past several years.

More Episodes

Podcast: The British start-up taking psychedelic therapy mainstream

Published 10/16/23

Published 10/16/23

The Biopharma Pod

Published 07/22/21